文献速递瓣膜病与结构性心脏病高血压

收缩压与瓣膜性心脏病风险的孟德尔随机化研究

Systolic Blood Pressure and Risk of Valvular Heart Disease: A Mendelian Randomization Study.
PubMed 文献 · JAMA Cardiol · 2019-01-01

IMPORTANCE: Modifiable risk factors for valvular heart disease remain largely unknown, which limits prevention and treatment. OBJECTIVE: To assess the association between systolic blood pressure (BP) and major valvular heart disease.…

要点

  • 遗传关联的收缩压每升高20 mmHg,主动脉瓣狭窄风险OR为3.26(95%CI 1.50-7.10)。
  • 主动脉瓣反流OR为2.59(95%CI 0.75-8.92),二尖瓣反流OR为2.19(95%CI 1.07-4.47)。

核心结论

  • 终生暴露于升高的收缩压可能与主要瓣膜性心脏病风险增加相关。

研究设计与样本

  • 采用孟德尔随机化方法,使用130个与收缩压独立关联(r2<0.1,次要等位基因频率>0.01)的单核苷酸多态性作为工具变量。

主要发现

  • 遗传关联的收缩压每升高20 mmHg,主动脉瓣狭窄OR为3.26(95%CI 1.50-7.10),主动脉瓣反流OR为2.59(95%CI 0.75-8.92),二尖瓣反流OR为2.19(95%CI 1.07-4.47)。

临床怎么用

  • 对于收缩压升高的患者,应考虑其可能增加主动脉瓣狭窄、主动脉瓣反流和二尖瓣反流风险,加强血压管理或有助于预防瓣膜性心脏病。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Modifiable risk factors for valvular heart disease remain largely unknown, which limits prevention and treatment. OBJECTIVE: To assess the association between systolic blood pressure (BP) and major valvular heart disease. DESIGN, SETTING, AND PARTICIPANTS: A UK Biobank population-based cohort of 502 602 men and women aged 40 to 96 years at baseline was evaluated through mendelian randomization using individual participant data. Inclusion criteria were valid genetic data and BP measurements. The participants were recruited between 2006 and 2010; data analysis was performed from June 2018 to January 2019. EXPOSURES: Systolic BP was measured during clinical assessment and instruments for the genetic effect of high BP were identified from variants that were independently (linkage disequilibrium threshold of r2<0.1) associated with systolic BP with minor allele frequency greater than 0.01. A total of 130 single-nucleotide polymorphisms that have been shown to be associated with systolic BP in a genome-wide association meta-analysis involving 1 million participants of European ancestry were selected. MAIN OUTCOMES AND MEASURES: Incident aortic stenosis, aortic regurgitation, and mitral regurgitation, individually and combined. Cases were largely based on hospital records linked to the UK Biobank with International Classification of Diseases and Health Related Problems, Tenth Revision codes. RESULTS: Of the 502 602 individuals screened, 329 237 participants (177 741 [53.99%] women; mean [SD] age, 56.93 [7.99] years) had valid genetic data and BP measurements; of this cohort, 3570 individuals (1.08%) had a diagnosis of valvular heart disease (aortic stenosis, 1491 [0.45%]; aortic regurgitation, 634 [0.19%]; and mitral regurgitation, 1736 [0.53%]). Each genetically associated 20-mm Hg increment in systolic BP was associated with an increased risk of aortic stenosis (odds ratio [OR], 3.26; 95% CI, 1.50-7.10), aortic regurgitation (OR, 2.59; 95% CI, 0.75-8.92), and mitral regurgitation (OR, 2.19; 95% CI, 1.07-4.47), with no evidence for heterogeneity by type of valvular heart disease (P = .90). Sensitivity analyses confirmed the robustness of the association. CONCLUSIONS AND RELEVANCE: Lifetime exposure to elevated systolic BP appears to be associated with an increased risk of major valvular heart disease.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Nazarzadeh M, Pinho-Gomes AC, Smith Byrne K, et al. Systolic Blood Pressure and Risk of Valvular Heart Disease: A Mendelian Randomization Study. JAMA Cardiol. 2019. PMID: 31290937. doi:10.1001/jamacardio.2019.2202

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。